GENEVA, Dec. 17 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Technology Transfer Center, NCI Shady Grove9609 Medical Center Dr., Room 1E-530, MSC 9702Bethesda, MD 20892-9702) filed a patent application (PCT/US2025/032497) for "FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF" on Jun 05, 2025. With publication no. WO/2025/255373, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO)...